Fenretinide: A p53-independent way to kill cancer cells
- 10 June 2005
- journal article
- review article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 331 (3), 810-815
- https://doi.org/10.1016/j.bbrc.2005.03.184
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Growth and DNA Damage-Inducible Transcription Factor 153 Mediates Apoptosis in Response to Fenretinide but Not Synergy between Fenretinide and Chemotherapeutic Drugs in NeuroblastomaMolecular Pharmacology, 2003
- Raft ceramide in molecular medicineOncogene, 2003
- The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 familyOncogene, 2003
- Mechanisms of free‐radical induction in relation to fenretinide‐induced apoptosis of neuroblastomaJournal of Cellular Biochemistry, 2003
- Ceramide Signaling in Fenretinide-induced Endothelial Cell ApoptosisPublished by Elsevier ,2002
- Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor‐α‐mediated apoptosis in human colon HT‐29 cells through glycosphingolipids formationFEBS Letters, 2002
- Enzymes of Sphingolipid Metabolism: From Modular to Integrative SignalingBiochemistry, 2001
- The Hallmarks of CancerCell, 2000
- Evidence for Direct Binding of Fatty Acids and Eicosanoids to Human Peroxisome Proliferators-Activated Receptor αBiochemical and Biophysical Research Communications, 1999
- Apoptosis of Human Neuroblastoma Cells Induced by Liposome-Encapsulated FenretinideJournal of Liposome Research, 1998